Adrenergics - Crunchbase Company Profile & Funding

Q: When was the last funding round for Adrenergics?

Adrenergics closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Adrenergics raised to date?

Adrenergics has raised obfuscated.

Overview

Adrenergics

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Adrenergics

Adrenergics Develops therapeutics to treat dilated cardiomyopathy which modulate disease progression.

Closed

Founded

obfuscation

Private

Series A

San Diego, California, United States

Biotechnology

Health Care

Medical

Therapeutics

Funding Rounds

Series A

OBF

obfuscation

Details

Legal Name

Adrenergics, Inc.

Operating Status

Closed

Company Type

For Profit

Founders

David Campbell

Predictions & Insights

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Adrenergics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Adrenergics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Adrenergics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Adrenergics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Adrenergics	—	obfuscated obfuscation	—	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Adrenergics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Adrenergics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Adrenergics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Adrenergics	—	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Adrenergics	—	obfuscated obfuscation	—	Series A